Indicators

Latest News about NVO

Recent news which mentions NVO

...

20 21 22 23 24 25 26 27 28

...

Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today

September 20, 2024

US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices

September 20, 2024

Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players

September 20, 2024

Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints

September 20, 2024

Novo Nordisk Stock Declines After Headline Results From Mid-Stage Study Of Monlunabant In Obese Patients

September 20, 2024

European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure

September 20, 2024

Hims & Hers To Offer Access To Compounded Diabetes And Weight Loss Drugs For Just $99/Month To Certain Professional Personnel

September 19, 2024

Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity

September 19, 2024

Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks

September 19, 2024

Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks

September 19, 2024

Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications

September 18, 2024

1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)

September 17, 2024

2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200

September 14, 2024

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

September 12, 2024

Why Roche Holdings Stock Withered on Wednesday

September 11, 2024

Why Viking Therapeutics Stock Rocked the Market Today

September 11, 2024

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,700 Today

September 11, 2024

Ozempic Maker Novo Nordisk Touts Encouraging Data From New Obesity Pill Showing Double Weight Loss Compared To Wegovy

September 11, 2024

Is Hims & Hers Health the Next Teladoc?

September 11, 2024

Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval

September 11, 2024

Evaluating Novo Nordisk: Insights From 8 Financial Analysts

September 09, 2024

Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?

September 07, 2024

What the Options Market Tells Us About Novo Nordisk

September 06, 2024

Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts

September 05, 2024

Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern

September 05, 2024

Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation

September 05, 2024

Novo Nordisk Unusual Options Activity

September 05, 2024

Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.

September 05, 2024

Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?

September 05, 2024

Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In

September 04, 2024

...

20 21 22 23 24 25 26 27 28

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.